Sorted news

Teva buying Auspex for $3.2 billion

Teva Pharmaceutical Industries Ltd. is buying Auspex Pharmaceuticals Inc. for about $3.2 billion in a move to strengthen its position on central nervous system condition treatments.

21 hours ago
popularity 3 comments 0

Future GPs could benefit from longer training

Newly-qualified GPs could be better prepared for practice by increasing the variety and duration of their training programme, according to research being published in the April 2015 issue of the British Jo ...

22 hours ago
popularity 2 comments 0

Oral hepatitis B vaccine could become a reality

In a new study, researchers report progress toward perfecting a radical new method of producing vaccines using genetically modified corn. The approach could lead to an oral hepatitis B vaccine that requires no refrigeration ...

Mar 30, 2015
popularity 13 comments 0